What is he best known for?
The fields of study he is best known for:
Valakunja Nagaraja spends much of his time researching DNA gyrase, DNA, Biochemistry, Mycobacterium tuberculosis and Genetics.
His research in DNA gyrase intersects with topics in Antibacterial agent, Microbiology and Mycobacterium smegmatis.
His DNA study combines topics in areas such as Molecular biology and Escherichia coli, Nucleoid.
His Molecular biology research is multidisciplinary, relying on both Plasmid and Enzyme.
Genome and Gene are among the areas of Genetics where Valakunja Nagaraja concentrates his study.
His studies in Genome integrate themes in fields like Computational biology, Transcription and Cellular defense.
His most cited work include:
- A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes (576 citations)
- Diverse Functions of Restriction-Modification Systems in Addition to Cellular Defense (307 citations)
- Diverse Functions of Restriction-Modification Systems in Addition to Cellular Defense (307 citations)
What are the main themes of his work throughout his whole career to date?
Valakunja Nagaraja mainly focuses on DNA, Biochemistry, Molecular biology, DNA gyrase and Mycobacterium smegmatis.
His DNA study introduces a deeper knowledge of Genetics.
The various areas that he examines in his Molecular biology study include Protein subunit and RNA polymerase.
His DNA gyrase study integrates concerns from other disciplines, such as DNA supercoil, Quinolone, Antibacterial agent and Mycobacterium tuberculosis.
His work investigates the relationship between Mycobacterium tuberculosis and topics such as Nucleoid that intersect with problems in Histone and DNA-binding protein.
Valakunja Nagaraja has included themes like Peptide sequence and Stereochemistry in his Mycobacterium smegmatis study.
He most often published in these fields:
- DNA (67.96%)
- Biochemistry (46.83%)
- Molecular biology (40.85%)
What were the highlights of his more recent work (between 2017-2021)?
- DNA (67.96%)
- Cell biology (18.66%)
- Transcription (39.08%)
In recent papers he was focusing on the following fields of study:
Valakunja Nagaraja mainly investigates DNA, Cell biology, Transcription, Topoisomerase and Gene.
His DNA study is concerned with Biochemistry in general.
His study in Cell biology is interdisciplinary in nature, drawing from both Cleavage, Mycobacterium tuberculosis, PI3K/AKT/mTOR pathway, Autophagosome and Calcium pump.
His Transcription research is multidisciplinary, incorporating perspectives in DNA gyrase, Mycobacterium smegmatis, Gene expression and Nucleoid.
His Topoisomerase study combines topics from a wide range of disciplines, such as Plasma protein binding, Transporter, RNA, Lysis and Tandem repeat.
Gene is a subfield of Genetics that he studies.
Between 2017 and 2021, his most popular works were:
- Genome-wide mapping of Topoisomerase I activity sites reveal its role in chromosome segregation (16 citations)
- Genome-wide mapping of Topoisomerase I activity sites reveal its role in chromosome segregation (16 citations)
- Physical and functional interaction between nucleoid-associated proteins HU and Lsr2 of Mycobacterium tuberculosis: altered DNA binding and gene regulation. (10 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Transcription, Nucleoid, RNA polymerase, Mycobacterium smegmatis and Gene expression.
The study incorporates disciplines such as DNA and Cell biology in addition to Nucleoid.
RNA polymerase is frequently linked to DNA gyrase in his study.
His Mycobacterium smegmatis research incorporates themes from Transcription factor, Gene, Transcriptional regulation and RRNA Operon.
His Transcription factor study is concerned with the larger field of Genetics.
He usually deals with Gene expression and limits it to topics linked to Mycobacterium tuberculosis and Pharmacology and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
